| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740484 | Journal of Infection | 2018 | 9 Pages |
Abstract
The UK has a broad research portfolio across a wide range of infectious diseases and disciplines. There are notable strengths including HIV, some respiratory infections and in pre-clinical science, though there was less funding for UK-relevant trials and public health research. Compared to the UK burden of disease, syphilis, gonorrhoea and pneumonia appear relatively neglected. Investment analyses can assist support policymakers to increase the equity of the UK R&D landscape.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Michael G. Head, Rebecca J. Brown, Stuart C. Clarke,